Displaying 981 - 1000 of 1585
Statement of FTC Chairman Jon Leibowitz On Passage of H.R. 3126, the Consumer Financial Protection Act of 2009 by the House Energy and Commerce Committee
FTC Order Restores Competition Lost Through Schering-Plough's Acquisition of Merck
U.S. Court of Appeals Enforces Subpoenas in FTCs Androgel Investigation; In Separate Case, FTC Files Petition to Compel Enforcement of Subpoena Issued to Boehringer Ingelheim
Statement of FTC Chairman Jon Leibowitz Regarding the Senate Judiciary Committee's Passage of the Preserve Access to Affordable Generics Act (S. 369)
FTC Order Prevents Anticompetitive Effects from Pfizers Acquisition of Wyeth
Commission Order Restores Competition Eliminated by Carilion Clinics Acquisition of Two Outpatient Clinics
A Healthcare Triptych
Thoratec Corporation, and HeartWare International, Inc., In the Matter of
The Commission authorized a preliminary injunction to block Thoratec Corporation’s proposed $282 million acquisition of rival medical device maker HeartWare International, Inc., charging that the transaction would substantially reduce competition in the U.S. market for left ventricular devices (LVADs), a life-sustaining treatment for patients with advanced heart failure. The FTC’s administrative complaint alleges that Thoratec seeks to maintain its monopoly by acquiring HeartWare, thus eliminating the only significant threat to Thoratec’s continued dominance of the LVAD market. In August of 2009, the parties announced they would not to proceed with the proposed acquisition, and the Commission dismissed the Administrative Complaint without filing an motion for preliminary injunction in federal court.
Statement by FTC Chairman Jon Leibowitz on Adoption of the Pay for Delay Amendment to the Americas Affordable Health Choices Act of 2009 by the House Energy and Commerce Committee
Bureau of Competition Statement Regarding the Announcement that Thoratec Corporation Will Not Proceed with Its Proposed Acquisition of HeartWare International
FTC Challenges Thoratec's Proposed Acquisition of HeartWare International
FTC Challenges Carilions Acquisition of Outpatient Medical Clinics
FTC Testifies on Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care
Commission Approves FY 2008 HSR Premerger Notification Report; FTC Approves Final Consent Order in Matter Concerning Alta Bates Medical Group
Alta Bates Medical Group, Inc.
Alta Bates Medical Group, Inc., a 600-physician independent practice association serving the Berkeley and Oakland, California, area, settleed Commission charges that it violated federal antitrust law by fixing prices charged to health care insurers. The consent order prohibits Alta Bates from collectively negotiating fee-for-service reimbursements and engaging in related anticompetitive conduct. In addition to price-fixing of fee-for-service reimbursements, the FTC’s complaint alleges an unlawful concerted refusal to deal.
FTC Issues Interim Report on "Authorized Generic" Drugs
FTC Chairman Leibowitz: Eliminating Pay-for-Delay Pharmaceutical Settlements Would Save Consumers $3.5 Billion Annually
Displaying 981 - 1000 of 1585